Multiprofile Hospital For Active Treatment Pazardzik AD

The department focuses on cardiovascular disease and related conditions, evaluating new therapies aimed at reducing heart attacks, stroke risk, and heart failure.

• Heart failure with reduced ejection fraction
• High cardiovascular risk patients
• Acute myocardial infarction
• Ischemic stroke prevention
• Hypertriglyceridemia management

Multiprofile Hospital For Active Treatment Pazardzik AD supports these studies through a dedicated cardiology team.

Research includes chronic obstructive pulmonary disease and metabolic disorders such as severe hypertriglyceridemia, aiming to improve patient outcomes with novel agents.

• COPD with type 2 inflammation
• Severe hypertriglyceridemia
• Hypertension management
• Metabolic risk reduction

The hospital’s integrated care model enables simultaneous assessment of lung function and metabolic health.

Trials address multiple sclerosis and immune‑mediated conditions, testing therapies that may slow disease progression and modulate immune response.

• Non‑relapsing secondary progressive MS
• Relapsing MS
• Immune system modulation
• Neuroinflammation

Patients benefit from coordinated neurology and immunology expertise at the site.

The unit investigates chronic spontaneous urticaria and vitiligo, focusing on treatments that reduce skin symptoms and improve quality of life.

• Chronic spontaneous urticaria activity
• Nonsegmental vitiligo
• Skin inflammation control

Dermatology specialists collaborate with cardiology to monitor systemic effects of therapies.

A pediatric program evaluates new antibiotics for complicated urinary tract infection and acute pyelonephritis, ensuring safety in young patients.

• Complicated urinary tract infection in children
• Acute pyelonephritis in pediatric population

The hospital’s pediatric unit provides a safe environment for these critical studies.